The effect of whey protein on blood pressure and vascular endothelial in mild hypertensive and prehypertensive patient

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15005756

Enrollment

Unknown

Registered

2014-10-21

Start date

2014-12-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

whey protein group:whey protein

control gorup:maltodextrin

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for primary hypertension, prehypertension: SBP is between 120-139mmHg and/or DBP is in 80-90mmHg, hypertension Class I (mildly level): SBP ranges from 140mmHg to 159mmHg or DBP ranges from 90mmHg to 99mmHg; 2. Aged between 18 and 70, male or female; 3. Signed the informed consent form.

Exclusion criteria

Exclusion criteria: Known or suspected secondary hypertension; coronary disease; diabetes; Hepatic and renal insufficiency; tumor; hyperthyroidism; cerebrovascular disease; Pregnancy or breast-feeding women.

Design outcomes

Primary

Measure	Time frame
blood pressure;flow mediated dilation;Carotid artery intima - media thickness;Vascular endothelial active substance;Plasma inflammatory factors;antioxidation index;	—

Countries

China

Contacts

Public ContactLiqiang Qin

qinliqiang@suda.edu.cn+86 13915543146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026